Company Filing History:
Years Active: 2010
Title: Klaus Döhler: Innovator in Heart Failure Treatment
Introduction
Klaus Döhler is a prominent inventor based in Hannover, Germany. He has made significant contributions to the field of medicine, particularly in the treatment of heart failure. His innovative approach has led to the development of a unique patent that addresses a critical health issue.
Latest Patents
Klaus Döhler holds a patent for the "Use of natriuretic peptide for treating heart failure." This invention relates to the use of a natriuretic peptide, such as urodilatin, for treating patients suffering from heart failure, including acute decompensated heart failure. The patent outlines a method where a composition comprising an effective amount of urodilatin is intravenously administered to the patient continuously for a period ranging from 24 to 120 hours, with a preference for at least 48 hours.
Career Highlights
Klaus Döhler is associated with Cardiopep Pharma GmbH, where he continues to work on innovative solutions for cardiovascular health. His dedication to research and development has positioned him as a key figure in the medical community.
Collaborations
Klaus has collaborated with notable professionals in his field, including Veselin Mitrovic and Hartmut Lüss. These partnerships have enhanced the scope and impact of his work in heart failure treatment.
Conclusion
Klaus Döhler's contributions to the medical field, particularly through his patent on natriuretic peptides, demonstrate his commitment to improving patient outcomes in heart failure. His work continues to inspire advancements in cardiovascular therapies.